Sign Up to like & get
recommendations!
1
Published in 2017 at "European Respiratory Journal"
DOI: 10.1183/1393003.congress-2017.oa3189
Abstract: Background: Thymic stromal lymphopoietin (TSLP) is an epithelial cytokine and key regulator of inflammatory pathways including type 2 responses. Tezepelumab is a human anti-TSLP monoclonal antibody that reduces the early and late phase asthmatic responses…
read more here.
Keywords:
efficacy safety;
severe asthma;
study;
adults severe ... See more keywords